Proportion of patients with increased or decreased liver iron concentration (LIC), according to iron intake and DFO dose. As with patients who received deferasirox, both the dose of DFO therapy and transfusional iron intake affected the proportion of patients achieving a reduction in LIC. The Cochran-Mantel-Haenszel test demonstrated a significant correlation between LIC response and iron intake category (P = .032).